NPFFR2
Basic information
Region (hg38): 4:72031902-72148305
Previous symbols: [ "GPR74" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (47 variants)
- not_provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPFFR2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004885.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 42 | 48 | ||||
nonsense | 0 | |||||
start loss | 1 | 1 | ||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 43 | 4 | 2 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NPFFR2 | protein_coding | protein_coding | ENST00000308744 | 4 | 116264 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.67e-7 | 0.653 | 125515 | 1 | 232 | 125748 | 0.000927 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.17 | 336 | 281 | 1.20 | 0.0000136 | 3461 |
Missense in Polyphen | 101 | 89.161 | 1.1328 | 1200 | ||
Synonymous | -1.62 | 126 | 105 | 1.20 | 0.00000533 | 992 |
Loss of Function | 1.15 | 13 | 18.3 | 0.711 | 8.70e-7 | 199 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00121 | 0.00121 |
Ashkenazi Jewish | 0.00239 | 0.00228 |
East Asian | 0.000707 | 0.000707 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000964 | 0.000959 |
Middle Eastern | 0.000707 | 0.000707 |
South Asian | 0.00100 | 0.000980 |
Other | 0.00263 | 0.00261 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for NPAF (A-18-F-amide) and NPFF (F-8-F-amide) neuropeptides, also known as morphine-modulating peptides. Can also be activated by a variety of naturally occurring or synthetic FMRF-amide like ligands. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol- calcium second messenger system.;
- Pathway
- Neuroactive ligand-receptor interaction - Homo sapiens (human);GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;Orexin and neuropeptides FF and QRFP bind to their respective receptors;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.0777
Intolerance Scores
- loftool
- 0.932
- rvis_EVS
- 0.36
- rvis_percentile_EVS
- 74.63
Haploinsufficiency Scores
- pHI
- 0.0549
- hipred
- N
- hipred_score
- 0.144
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0771
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Npffr2
- Phenotype
- cellular phenotype; hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;neuropeptide signaling pathway;detection of abiotic stimulus;cellular response to hormone stimulus;regulation of MAPK cascade;regulation of adenylate cyclase activity;regulation of cAMP-dependent protein kinase activity
- Cellular component
- plasma membrane;integral component of plasma membrane;actin cytoskeleton
- Molecular function
- G protein-coupled receptor activity;neuropeptide receptor activity;opioid receptor binding